Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganoderma lucidum + saffron is a combination of two natural substances commonly used in traditional and complementary medicine. Ganoderma lucidum, also known as reishi or lingzhi, is a medicinal mushroom with a long history in Traditional Chinese Medicine. It contains bioactive compounds such as triterpenes and polysaccharides that are believed to have immunomodulatory, anti-inflammatory, antioxidant, and potential neuroprotective effects[3][4]. Saffron (Crocus sativus) is a spice derived from the flower of Crocus sativus and has been studied for its antioxidant properties and possible benefits for mood regulation and cognitive function. The combination is typically marketed as a dietary supplement aimed at supporting immune health, stress adaptation (adaptogen), or general wellness. There are no proven pharmaceutical indications for this combination; it is not an approved drug but rather used as a food supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ganoderma lucidum + saffron.